← Back to headlines
Apellis Pharma Stock Surges Following Biogen Deal
Apellis Pharma's stock has seen a significant surge following a deal with Biogen, leading investors to question if it's too late to capitalize on the APLS stock rally.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
ETH Zurich Neighborhood Evacuated Due to Dangerous Chemical Transport
25m ago
Czech Theater Stages Play on Manuscript Authenticity Controversy with AI and Puppets
28m ago
Lego Unveils Largest-Ever Sagrada Familia Set with 12,060 Pieces
45m ago